Neuroscience
Alzheimer's Disease
89%
Hippocampus
66%
Cholinergic
60%
Synapse
55%
Apolipoprotein A
50%
Akt Signaling
50%
Tectum
50%
Presenilin 1
50%
Long-Term Depression
50%
Simvastatin
50%
Cerebral Amyloid Angiopathy
50%
Long-Term Potentiation
50%
Extracellular Signal-Regulated Kinases
50%
Physostigmine
50%
Acetylcholinesterase Inhibitor
50%
Glycogen Synthase Kinase 3
50%
Amyloid Precursor Protein
50%
Cholinergic Receptor
37%
Statin
33%
Carbachol
32%
Acetylcholinesterase
30%
Protein Kinase B
27%
In Vivo
25%
High-Density Lipoprotein
22%
Synaptic Transmission
18%
Circadian Rhythm
16%
Glycogen Synthase
16%
Cell Stress
16%
Amnesia
16%
Imaging Technique
12%
Parkinson's Disease
12%
High Density Lipoprotein Cholesterol
11%
Learning Disabilities
11%
Parasympathetic Innervation
10%
Glutamic Acid
10%
Synaptic Plasticity
10%
Eicosanoid Receptor
10%
Anabolism
5%
Chemokine
5%
Cell Membrane Potential
5%
Brain Slice
5%
In Vitro
5%
Synapsin I
5%
Traumatic Brain Injury
5%
Neurotrauma
5%
Amyloid
5%
Water Maze
5%
Anti-Inflammatory
5%
Biochemistry, Genetics and Molecular Biology
Long Term Potentiation
100%
Simvastatin
100%
C57BL 6 Mouse
56%
Farnesyl Pyrophosphate
50%
Statin
33%
Transgenic Mouse
23%
Cognition
18%
Anabolism
11%
Oxidoreductase
11%
Reductase
11%
Protein Kinase B
11%
Geranylgeranyl Pyrophosphate
6%
Isoprenylation
6%
Geranylgeranylation
6%
Pleiotropy
6%
Farnesyltransferase
6%
Mouse Model
6%
Amyloid Beta
6%
Wild Type
6%
Phosphoinositide 3-Kinase
6%
Hypercholesterolemia
6%
Competitive Inhibition
6%
Synaptic Transmission
5%
Cell Membrane Potential
5%
Genetic Background
5%
Cholesterol Blood Level
5%
Pulse Rate
5%
Cholesterol Level
5%
Prospective Study
5%
Prevalence
5%
Synapse
5%
Pharmacology, Toxicology and Pharmaceutical Science
C57BL 6 Mouse
50%
Physostigmine
50%
Cholinesterase Inhibitor
50%
Simvastatin
50%
Acetylcholinesterase
30%
Alzheimer's Disease
26%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
22%
Carbachol
20%
Cholinergic Receptor Stimulating Agent
20%
Protein Kinase B
11%
Transgenic Mouse
11%
Statin (Protein)
11%
Glutamic Acid
10%
Receptor
10%
Combination Therapy
10%
Traumatic Brain Injury
5%
Prevalence
5%
Oxidoreductase
5%
Cardiovascular Disease
5%
Prospective Study
5%